Where is LineaRx located?

LineaRx is headquartered in Stony Brook, United States.

How many employees does LineaRx have?

As of May 31, 2026, the latest employee count at LineaRx is 2.

Where does LineaRx rank among its competitors?

LineaRx ranks 9th amongst 58 active competitors, of which 11 are funded. It stands 10th in terms of total funding among its competitors. The most recent competitor to raise funding was Igenesis, which secured an undisclosed amount in Mar, 2022.

Who are the top competitors of LineaRx?

LineaRx's top competitors include Stilla Technologies, NeuMoDx and GenMark Diagnostics. Among them, Igenesis secured the most recent funding round in March, 2022.

LineaRx - 2026 Company Profile, Team & Competitors

LineaRx is an unfunded company based in Stony Brook (United States), founded in 2018 by James Hayward. It operates as a Provider of a platform for the production of DNA sequences. LineaRx has not raised any funding yet. The company has 58 active competitors, including 11 funded and 9 that have exited. Its top competitors include companies like Stilla Technologies, NeuMoDx and GenMark Diagnostics.

Company Details

Provider of a platform for the production of DNA sequences. The company is also offering research contracts services for companies producing DNA, RNA vaccines, and adoptive cell therapies.

Website: linearxdna.com
Social
Email ID: *****@adnas.com
Phone Number: +1 **********

Key Metrics

Founded Year

2018

Location

Stony Brook, United States

Stage

Unfunded

Ranked

9^th among 58 active competitors

Employee Count

2 as on May 31, 2026

Investment & Acquisitions

Vitatex

Similar Companies

Stilla Technologies & 73 more

View LineaRx's full profile

LineaRx has not raised any funding rounds yet.

The founders of LineaRx is James Hayward.

Here are the details of LineaRx's key team members:

James Hayward: Co-Founder / President of LineaRx.

View details of LineaRx's Founder profiles and Board Members

LineaRx's employee count trend

LineaRx has 2 employees as of May 26. Here is LineaRx's employee count trend over the years:

Uncover LineaRx's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of LineaRx include Stilla Technologies, NeuMoDx and GenMark Diagnostics. Here is the list of Top 10 competitors of LineaRx, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Stilla Technologies 2013, Villejuif (France), Acquired	Developer of digital PCR solution for research	$53.1M	Illumina Ventures, LBO France & 11 others	64/100
2nd	NeuMoDx 2012, Ann Arbor (United States), Acquired	Developer of a platform for low cost molecular testing	$66M	Arboretum Ventures, Wolverine Venture Fund ... & 3 others	58/100
3rd	GenMark Diagnostics 1993, San Diego (United States), Acquired	Provider of instruments and test panels for multiplexed molecular diagnostics	$8.56M	SLR Investment Corp, VIDANT Capital	49/100
4th	Silicon Biosystems 1999, Bologna (Italy), Acquired	Developer of lab on a chip technologies for miniaturized cell-biology testing	$25.5M	Indaco Venture Partners, Innogest Capital ... & 1 others	46/100
5th	Biomeme 2013, Philadelphia (United States), Series A	Developer of a smartphone-based DNA detection platform	$6.2M	Ben Franklin Technology Partners, SeedFord Partners ... & 10 others	42/100
6th	Prominex 2016, San Diego (United States), Series A	Provider of point-of-care molecular diagnostic solution	$4M	Casdin Capital, JLABS	40/100
7th	Igenesis 2015, Shanghai (China), Series C	Provider of automated PCR analysis platfrom	$13M	Morningside, Shanghai Kehua Bio-engineering ... & 5 others	39/100
8th	miniPCR 2013, Cambridge (United States), Funding Raised	Developer of easy-to-use PCR and electrophoresis instruments	-	MassChallenge	39/100
9th	LineaRx 2018, Stony Brook (United States), Unfunded	Provider of a platform for the production of DNA sequences	-	-	39/100
10th	XCR Diagnostics 2015, Park City (United States), Seed	Provider of a portable device for nucleic acid testing	$2.5M	-	38/100